Pro- and anti-inflammatory actions of thrombin: A distinct role for proteinase-activated receptor-1 (PAR1)

British Journal of Pharmacology

Volumn 126, Issue 5, 1999, Pages 1262-1268

  Vergnolle, Nathalie ^a   Hollenberg, Morley D ^b   Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Inflammation; Mast cell; Nitric oxide; Prostaglandin; Protease activated receptor; Thrombin

Indexed keywords

COMPOUND 48-80; HIRUDIN; INDOMETACIN; THROMBIN; THROMBIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INFLAMMATION; MALE; MAST CELL; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

EID: 0032975515     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702408     Document Type: Article

References (38)

1. BAR-SHAVIT, R., KAHN, A., MUDD, M.S., WILNER, G.D., MANN, K.G. & FENTON, J.W. (1984). Localization of a chemotactic domain in human thrombin. Biochemistry, 23, 397-400.
2. BAR-SHAVIT, R., KAHN, A., WILNER, G.D. & FENTON, J.W. (1983). Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science, 220, 728-731.
3. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J. Biol. Chem., 269, 15625-15630.
4. BILLS, T.K., SMITH J.B. & SILVER, M.J. (1977). Selective release of arachidonic acid from the phospholipids of human platelets in response to thrombin. J. Clin. Invest., 60, 1-6.
5. BIZIOS, R., LAI, L., FENTON, J.W. & MALIK, A.B. (1986). Thrombin-induced chemotaxis and aggregation of neutrophils. J. Cell. Physiol., 128, 485-490.
6. BLACKHART, B.D., EMILSSON, K., NGUYEN, D., TENG, W., MARELLI, A.J., NYSTED, T.S., SUNDELIN J. & SCARBOROUGH, R.M. (1996). Ligand cross-reactivity within the protease-activated receptor family. J. Biol. Chem., 271, 16466-16471.
7. CIRINO, G., CICALA, C., BUCCI, M.R., SORRENTINO, L., MARAGANORE, J.M. & STONE, S.R. (1996). Thrombin functions as an inflammatory mediator through activation of its receptor. J. Exp. Med., 183, 821-827.
8. DI ROSA, M., GIROUD, J.P. & WILLOUGHBY, D.A. (1971). Studies of the mediators of the acute inflammatory response induced in rats at different sites by carrageenan and turpentine. J. Pathol., 104, 15-29.
9. DRAIJER, R., ATSMA, D.E., VAN DER LAARSE, A. & HINSBERGH, V.W.M. (1995). cGMP and nitric oxide modulate thrombin-induced endothelial permeability: Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ. Res., 76, 199-208.
10. GLENN, K.C., FROST, G.H., BERGMANN, J.S. & CARNEY, D.H. (1988). Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis. Peptide Res., 1, 65-73.
11. HERBERT, J.M., DUPUY, E., LAPLACE, M.C., ZINI, J.M., BARSHAVIT, R. & TOBELEM, G. (1994). Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem. J., 303, 227-231.
12. HOLLENBERG, M.D. (1996). Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol. Sci., 17, 3-6.
13. HOLLENBERG, M.D., MOKASHI, S., LEBLOND, L. & DI MAIO, J. (1996). Synergistic actions of a thrombin-derived synthese peptide and a thrombin receptor-activating peptide in stimulating fibroblast mitogenesis. J.Cell. Physiol., 169, 491-496.
14. HOLLENBERG, M.D., SAIFEDDINE, M., AL-ANI, B. & KAWABATA, A., (1997). Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can. J. Physiol. Pharmacol., 75, 832-841.
15. HOLLENBERG, M.D., YANG, S.G., LANIYONU, A.A., MOORE, G.J. & SAIFEDDINE, M. (1992). Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity. Mol. Pharmacol., 42, 186-191.
16. ISHIHARA, H., CONNOLLY, A.J., ZENG, D., KAHN, M.L., ZHENG, Y.W., TIMMONS, C., TRAM, T. & COUGHLIN, S.R. (1997). Protease-activated receptor 3 is a second thrombin receptor in humans. Nature, 386, 502-506.
17. KAHN, M.L., ZHENG, Y.W., HUANG, W., BIGORNIA, V., ZENG, D., MOFF, S., FARESE Jr, R.V., TAM, C., COUGHLIN, S.R. (1998). A dual thrombin receptor system for platelet activation. Nature, 394, 690-694.
18. KAWABATA, A., KURODA, R., MINAMI, T., KATAOKA, K. & TANEDA, M. (1998). Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol., 125, 419-422.
19. KAWABATA, A., SAIFEDDINE, M., AL-ANI, B., LEBLOND, L. & HOLLENBERG, M.D. (1999). Evaluation of proteinase-activated receptor-1 (PAR-1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR-2 by PAR-1 targeted ligands. J. Pharm. Exp. Ther., 288, 358-370.
20. 2 in human platelets. J. Biol. Chem., 268, 26796-26804.
21. KRANZHOFER, R., CLINTON, S.K, ISHII, K, COUGHLIN, S.R., FENTON, J.W. & LIBBY, P. (1996). Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ. Res., 79, 286-294.
22. MALIK, A.B. & FENTON, J.W. (1992). Thrombin-mediated increase in vascular endothelial permeability. Sem. Thrombos. Hemostas., 18, 193-199.
23. MARAGANORE, J.M., BOURDON, P., JABLONSKI, J., RAMACHANDRAN, K.L. & FENTON, J.W. (1990). Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry, 29, 7095-7101.
24. NELKIN, N.A., SOIFER, S.J., O'KEEFE, J., VU, T.K., CHARO, I.F. & COUGHLIN, S.R. (1992). Thrombin receptor expression in normal and atherosclerotic human arteries. J. Clin. Invest., 90, 1614-1621.
25. NYSTEDT, S., EMILSSON, K., WAHLESTEDT, C. & SUNDELIN, J. (1994). Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U.S.A., 91, 9208-9212.
26. 2+ mobilization. FEBS Lett., 288, 123-128.
27. RAZIN, E. & MARX, G. (1984). Thrombin-induced degranulation of cultured bone marrow-derived mast cells. J. Immunol., 133, 3282-3285.
28. SKRZYPCZAK-JANKUN, E., CARPEROS, V.E., RAVICHANDRAN, K.G, TULINSKY, A., WESTBROOK, M. & MARAGANORE, J.M. (1991). Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. J. Mol. Biol., 221, 1379-1393.
29. STANKOVA, J., ROLA-PLESZCZYNSKI, M. & D'ORLEANS-JUSTE, P. (1995). Endothelin 1 and thrombin synergistically stimulate IL-6 mRNA expression and protein production in human umbilical vein endothelial cells. J. Cardiovasc. Pharmacol., 26, S505-S507.
30. STIERNBERG, J., REDIN, W.R., WARNER, W.S. & CARNEY, D.H. (1993). The role of thrombin and thrombin receptor activating peptide (TRAP-508) in initiation of tissue repair. Thromb. Haemostas., 70, 158-162.
31. TAY-UYBOCO, J., POON, M.C., AHMAD, S. & HOLLENBERG, M.D. (1995). Contractile actions of thrombin receptor-derived polypeptides in human umbilical and placental vasculature: evidence for distinct receptor systems. Br. J. Pharmacol., 115, 569-578.
32. TOOTHILL, V.J., VAN MOURIK, J.A., NIEWENHUIS, H.K., METZELAAR, M.J. & PEARSON, J.D. (1990). Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J. Immunol., 145, 283-291.
33. UENO, A., MURAKAMI, K., YAMANOUCHI, K., WATANABE, M. & KONDO, T. (1996). Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells. Immunology, 88, 76-81.
34. VASSALLO, R.R., KIEBER-EMMONS, T., CICHOWSKI, K. & BRASS, L.F. (1992). Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J. Biol. Chem., 267, 6081-6085.
35. VERGNOLLE, N., MACNAUGHTON, W.K., AL-ANI, B., SAIFEDDINE, M., WALLACE, J.L. & HOLLENBERG, M.D. (1998). Proteinase-activated receptor-2-activating peptides: identification of a receptor that regulates intestinal transport. Proc. Natl. Acad. Sci. U.S.A., 95, 7766-7771.
36. VU, T.K., HUNG, D.T., WHEATON, V.I. & COUGHLIN, S.R. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64, 1057-1068.
37. WEKSLER, B.B., LEY, C.W. & JAFFE, E.A. (1978). Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A23187. J. Clin. Invest., 63, 923-930.
38. XU, W., ANDERSEN, H., WHITMORE, T.E., PRESNELL, S.R., YEE, D.P., CHING, A., GILBERT, T., DAVIE, E.W & FOSTER, D.C. (1998). Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U.S.A., 95, 6642 6646.